The leader in AI in radiotherapy treatment decision support Siris Medical, Inc was founded with the vision of improving treatment delivery and outcomes for patients undergoing radiation therapy for cancer treatment. Siri's predictive software informs clinicians of treatment plan outcomes in real-time, enabling data-driven radiation oncology decision-making with Artificial Intelligence (AI).

Siris Medical improves oncology outcomes through AI-enabled decisions based on analysis and comparison of over 10 million clinical images and over 30,000 expert treatments. InsightRT : the Siris Medical commercialized, FDA-cleared software suite, uses AI to match each new patient to a massive, proprietary, expert database in order to precisely tailor treatment to each patient’s unique characteristics. InsightRT leads to faster, better clinical decision-making with better clinical outcomes for patients and more cost-effective care delivery for payers.